AbbVie Investor Says Brass Exposed Co. To Off-Label Claims
An AbbVie Inc. shareholder launched a derivative suit Thursday in Delaware Chancery Court accusing the biopharmaceutical company's brass of saddling it with the risk of liability connected to whistleblower accusations of...To view the full article, register now.
Already a subscriber? Click here to view full article